The first healthcare product of Alnapharm is the dietary supplement OSVALIN®. OSVALIN® is a unique silicon preparation containing hydrolyzed, colloidal silicon dioxide in the highest possible concentration.
The content of these internet pages has been carefully drafted, developed and checked. However, Alnapharm GmbH & Co.KG gives no guarantee for the the topicality, correctness, completeness or quality of the information provided. Liability claims against Alnapharm GmbH & Co.KG that are based on material or non-material loss caused by the use or non-use of the information on offer or by erroneous and incomplete information, are generally excluded, inasmuch as there is no gross negligence on the part of Alnapharm GmbH & Co.KG. Alnapharm GmbH & Co.KG expressly retains the right to amend, update or delete sections, or the entirety, of the internet site or to cease publication without prior notification.
This disclaimer is to be regarded as part of the internet publication from which you were referred. If parts or individual clauses should fail to correspond to the prevailing legal situation, either wholly or in part, then the content and validity of the remaining parts shall remain unaffected.
Alnapharm GmbH & Co.KG endeavours to uphold copyrights for all publications. Should there be any breach of copyright Alnapharm GmbH & Co.KG will on notification delete, or acknowledge the copyright of the object, logo or text. All brands and trademarks, and third-party protected brands and trademarks, appearing within the the internet site, are unrestrictedly subject to the rules of the appropriate trademark and ownership regulations of each registered owner. The fact that a trademark has merely been named shall not imply that the trademark is not protected by the rights of third persons. The copyright for the content on the internet site www.alnapharm.com is owned by Alnapharm GmbH & Co.KG. Duplication of images, sounds and text in other electronic or printed material is expressly prohibited without written permission from Alnapharm GmbH & Co.KG.